Agile Therapeutics Cash from Financing (TTM) Analysis

Agile Therapeutics Inc (AGRX)

0.375 -0.04 (-9.57%) USD | OTCM | May 09, 16:00

Cash from Financing (TTM) Chart

Historical Cash from Financing (TTM) Data

View and export this data back to 2013. Upgrade now.

Date	Value
December 31, 2023	6.888M
September 30, 2023	8.035M
June 30, 2023	18.13M
March 31, 2023	23.48M
December 31, 2022	22.18M
September 30, 2022	42.60M
June 30, 2022	35.04M
March 31, 2022	29.42M
December 31, 2021	30.42M
September 30, 2021	9.666M
June 30, 2021	7.404M
March 31, 2021	0.975M
December 31, 2020	67.98M
September 30, 2020	87.11M
June 30, 2020	100.00M
March 31, 2020	101.24M
December 31, 2019	42.42M
September 30, 2019	17.03M
June 30, 2019	2.449M
March 31, 2019	-0.602M
December 31, 2018	-10.89M

Date	Value
September 30, 2018	-6.451M
June 30, 2018	12.26M
March 31, 2018	12.45M
December 31, 2017	13.08M
September 30, 2017	14.58M
June 30, 2017	-2.603M
March 31, 2017	-1.147M
December 31, 2016	37.69M
September 30, 2016	37.74M
June 30, 2016	38.14M
March 31, 2016	38.30M
December 31, 2015	19.98M
September 30, 2015	19.99M
June 30, 2015	19.76M
March 31, 2015	72.22M
December 31, 2014	52.66M
September 30, 2014	52.66M
June 30, 2014	52.66M
March 31, 2014	0.0298M
December 31, 2013	0.07M

Cash From Financing Definition

Cash flow from financing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall financing activities of the company. A few examples of financing activities include common stock issuance, total dividends paid, and net debt issuance.

Read full definition.

Cash from Financing (TTM) Range, Past 5 Years

0.975M

Minimum

Mar 2021

101.24M

Maximum

Mar 2020

34.34M

Average

23.48M

Median

Mar 2023

Cash from Financing (TTM) Benchmarks